Fagron Genomics - Tools for personalized clinical practice

Fagron Genomics is a cutting-edge healthcare technology company that is transforming the way we approach patient care. His groundbreaking research and innovative solutions are paving the way for more personalized and effective treatments, with a focus on genetic testing and analysis.

Fagron's history of genomics

Fagron Genomics was founded in 1990 as a small-scale compounding pharmacy in Rotterdam, the Netherlands. Over the years, the company has become a world leader in personalized medicine, with a focus on innovative genetic testing and analysis.

In 2014, Fagron Genomics launched the world's first Pharmacogenetic Testing Service, which analyzes a patient's DNA to determine how they may respond to certain drugs. This innovative technology has revolutionized the way physicians and pharmacists approach medication management, leading to more personalized and effective treatment plans.

technology and solutions

Fagron Genomics offers a wide range of cutting-edge solutions for personalized medicine, including genetic testing, pharmacogenetic testing, and nutrigenomics. Its advanced technology and analytical tools enable accurate and precise testing, with results delivered quickly and efficiently.

One of its most innovative solutions is the GeneScore test, which analyzes a patient's DNA to determine their risk for various diseases and conditions. This information can be used to create a personalized prevention plan, with a focus on lifestyle changes and early detection.

Challenges in health care

The healthcare industry is facing a number of challenges, from rising costs to a shortage of skilled professionals. However, one of the biggest challenges is the lack of personalized treatment options. Traditional medicine approaches patients with a "one size fits all" mentality, which often leads to ineffective or even harmful treatments.

Fagron Genomics is helping to meet this challenge by providing personalized medicine options that are tailored to each individual patient. By analyzing a patient's DNA and other key factors, they can create a treatment plan that is uniquely tailored to their needs and goals.